| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $4.57 ▼ -1.06% | wingi | $4.64 ▲ +0.45% | Sesuk Prelude Therapeutics Incorporated Common Stock (PRLD) persiyapan wis anchored kanggo $4.62 lan target $4.57 (-1.06%). Waca sing cedhak yaiku kekurangane; nonton $4.76 / $4.48 amarga volatilitas sing diwujudake saben dina babagan 5.47%. |
Sesuk Prelude Therapeutics Incorporated Common Stock (PRLD) persiyapan wis anchored kanggo $4.62 lan target $4.57 (-1.06%). Waca sing cedhak yaiku kekurangane; nonton $4.76 / $4.48 amarga volatilitas sing diwujudake saben dina babagan 5.47%. | ||||
| Minggu | $4.47 ▼ -3.30% | Minggu kepungkur | $4.68 ▲ +1.39% | Model 7 dina Prelude Therapeutics Incorporated Common Stock pindhah saka $4.68 menyang $4.47 (-3.30%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $4.76 / $4.48 prakara luwih saka siji obah. |
Model 7 dina Prelude Therapeutics Incorporated Common Stock pindhah saka $4.68 menyang $4.47 (-3.30%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $4.76 / $4.48 prakara luwih saka siji obah. | ||||
| wulan | $4.30 ▼ -7.03% | Wulan kepungkur | $4.76 ▲ +2.95% | Target 1 wulan Prelude Therapeutics Incorporated Common Stock yaiku $4.30 (-7.03%), dibandhingake karo referensi langsung ing cedhak $4.62. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Prelude Therapeutics Incorporated Common Stock yaiku $4.30 (-7.03%), dibandhingake karo referensi langsung ing cedhak $4.62. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $4.04 ▼ -12.62% | Taun kepungkur | $4.86 ▲ +5.30% | Skenario 1 taun Prelude Therapeutics Incorporated Common Stock nuduhake $4.04 (-12.62%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Prelude Therapeutics Incorporated Common Stock nuduhake $4.04 (-12.62%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $3.43 ▼ -25.71% | 5 Taun kepungkur | $5.12 ▲ +10.80% | Tampilan 5 taun Prelude Therapeutics Incorporated Common Stock yaiku $3.43 (-25.71%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Prelude Therapeutics Incorporated Common Stock yaiku $3.43 (-25.71%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $4.62 | agêng |
| Ganti saben dina | +2.44% | Ndhuwur |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 62% | Ngisor |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $4.62 | Ganti saben dina | +2.44% |
| Pasar Kab | $291.07M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.